Scotiabank Keeps Their Buy Rating on Healthcare Realty Trust (HR)
In a report released today, Nicholas Yulico from Scotiabank maintained a Buy rating on Healthcare Realty Trust, with a price target of $20.00.
Valentine's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Yulico covers the Real Estate sector, focusing on stocks such as SL Green Realty, Douglas Emmett, and Kilroy Realty. According to TipRanks, Yulico has an average return of 2.1% and a 48.89% success rate on recommended stocks.
In addition to Scotiabank, Healthcare Realty Trust also received a Buy from BTIG’s Michael Gorman in a report issued yesterday. However, today, BMO Capital maintained a Hold rating on Healthcare Realty Trust (NYSE: HR).
Based on Healthcare Realty Trust’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $297.77 million and a GAAP net loss of $57.74 million. In comparison, last year the company earned a revenue of $315.42 million and had a GAAP net loss of $93.02 million
Read More on HR:
Disclaimer & DisclosureReport an Issue
- Hold Rating Maintained as Operational Strength Offsets Limited 2026 FFO Growth Upside
- Healthcare Realty Trust announces $600M commercial paper program
- Healthcare Realty Trust Reports Q4 Results, Highlights Transformation
- Healthcare Realty Trust reports Q4 normalized EPS 40c, consensus 39c
- Healthcare Realty Trust sees FY26 normalized FFO $1.58-$1.64, consensus $1.60
